(Q52941618)

9 May 2018

title

The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. (English)

1 reference

9 May 2018

xanthine oxidase inhibitor

main subject

steatohepatitis

0 references

0 references

author

Akifumi Kushiyama

3

1 reference

9 May 2018

author name string

Yusuke Nakatsu

1

1 reference

9 May 2018

Yasuyuki Seno

2

1 reference

9 May 2018

Hideyuki Sakoda

4

1 reference

9 May 2018

Midori Fujishiro

5

1 reference

9 May 2018

Aya Katasako

6

1 reference

9 May 2018

Keiichi Mori

7

1 reference

9 May 2018

Yasuka Matsunaga

8

1 reference

9 May 2018

Toshiaki Fukushima

9

1 reference

9 May 2018

Ryuhei Kanaoka

10

1 reference

9 May 2018

Takeshi Yamamotoya

11

1 reference

9 May 2018

Hideaki Kamata

12

1 reference

9 May 2018

Tomoichiro Asano

13

1 reference

9 May 2018

publication date

21 May 2015

1 reference

9 May 2018

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

9 May 2018

volume

309

1 reference

9 May 2018

page(s)

G42-51

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Mitochondrial reactive oxygen species in cell death signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic beta-cell dysfunction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Febuxostat ameliorates diabetic renal injury in a streptozotocin-induced diabetic rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

A causal role for uric acid in fructose-induced metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Uric acid secretion from adipose tissue and its increase in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

Uric acid, hypertension, and cardiovascular and renal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00443.2014

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00443.2014

1 reference

9 May 2018

PubMed ID

25999428

1 reference

9 May 2018